Medical Device Industry Needs to Prepare for Disruptive Changes: Report | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Medical Device Industry Needs to Prepare for Disruptive Changes: Report

October 20, 2014
by John DeGaspari
| Reprints
Purchasing decisions will be increasingly influenced by evidence-based care, cost and value

A report released by A.T. Kearney says that disruptive changes taking place in healthcare will change the competitive landscape of the medical device industry, and that device manufacturers will need to look at new segments and end-to-end solutions that are focused on differentiated sources of value, customer productivity, and total patient disease management.

The findings of the study, Medical Devices: Equipped for the Future? were based on interviews with 30 medical device industry executives from 20 of the world’s leading medical device manufacturers. The report’s authors asked the executives about industry dynamics and what they see as disruptive forces, particularly in the “physician-preferred” segment, or products where the clinician has a large influence on purchasing decisions. It identifies five major medical device industry disruptors:

Power shift to payers and providers: Evidence-based decisions and the funding channels are increasingly challenging the traditional business model of clinician choice. Payers and providers are evaluating medical devices based on safety and procedural efficacy as well as cost and value. The report also noted that more patients are being covered by accountable care organizations (ACOs) that focus on better coordinated, lower cost care. In addition, hospital consolidation continues, with 20 percent of hospitals involved in M&A activity over the last five years. This led to the creation of large providers and umbrella networks that coordinate care pathways monitor costs. While physician preferences still matter, their freedom to choose can no longer be taken for granted. Costs and preferred supplier lists are playing a larger role in purchasing decisions, as pressure from price reductions have increased over the last few years.

New healthcare delivery models: Analytical tools are making it easier to evaluate large volumes of data, and patient pathways are being modified to obtain better outcomes for less money. For example, increasingly the emphasis is to shift care out of hospitals and into the community. Many medical procedures and follow-up examinations that were once routinely performed in specialized facilities are now done in an ambulatory center, in a primary-care physician’s office, or in the patient’s home. Nurse practitioners, pharmacists, therapists and social workers are all playing a greater role in patient care that is supported by technology such as enhanced data and remote access and monitoring tools, which are leading providers as well as device manufacturers to devise new care delivery models. There will be a need to direct products to new physical locations for use by different groups of providers, as well as a need for more complete, bundled, end-to-end solutions and services that go beyond the medical device itself.

Heightened regulatory scrutiny: Regulators have been tightening up existing regulations and adding new ones. FDA audits have increased by 40 percent in the past 12 months and the number of warning letters has risen by 24 percent over the past two years, with a rise in compliance costs. 

Need to focus on underserved populations: The report notes that the Affordable Care Act is focused on providing healthcare access to socio-demographic groups that have been traditionally underserved. Medical device companies seeking growth will need to target less affluent segments that can offer significant profit potential with the right solutions. Accessing growth segments, even in traditional markets, will require new business models, lower price points, and more value-based product offerings than those of today. 

Unclear sources of innovation: Because of regulatory and reimbursement issues, medical device companies are focusing their R&D efforts on improving already approved devices rather than developing truly innovative new products. New products that affect the way standardized procedures are conducted are often reluctantly included on the list of reimbursable products. Additionally, startups and small companies are finding it difficult to find capital to fund the increasing cost to bring new innovations to market, according to the report.

Topics

Comments

Over the years medical device industry has been growing rapidly with great new technologies. New healthcare medical devices are being used everywhere to obtain better outcomes in less money. However, some disruptive changes which you have mentioned above are also undergoing that should be immediately solved by companies. I think the most important concern is about medical device cyber security as they all are directly connected to software or networks which always have security issues

News

NewYork-Presbyterian, Walgreens Partner on Telemedicine Initiative

NewYork-Presbyterian and Walgreens are collaborating to bring expanded access to NewYork-Presbyterian’s healthcare through new telemedicine services, the two organizations announced this week.

ONC Releases Patient Demographic Data Quality Framework

The Office of the National Coordinator for Health IT (ONC) developed a framework to help health systems, large practices, health information exchanges and payers to improve their patient demographic data quality.

AMIA, Pew Urge Congress to Ensure ONC has Funding to Implement Cures Provisions

The Pew Charitable Trusts and the American Medical Informatics Association (AMIA) have sent a letter to congressional appropriators urging them to ensure that ONC has adequate funding to implement certain 21st Century Cures Act provisions.

Former Michigan Governor to Serve as Chair of DRIVE Health

Former Michigan Governor John Engler will serve as chair of the DRIVE Health Initiative, a campaign aimed at accelerating the U.S. health system's transition to value-based care.

NJ Medical Group Launches Statewide HIE, OneHealth New Jersey

The Medical Society of New Jersey (MSNJ) recently launched OneHealth New Jersey, a statewide health information exchange (HIE) that is now live.

Survey: 70% of Providers Using Off-Premises Computing for Some Applications

A survey conducted by KLAS Research found that 70 percent of healthcare organizations have moved at least some applications or IT infrastructure off-premises.